StoneX Group’s HUMANIGEN, INC. HGEN Stock Holding History

StoneX Group’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,134	Closed	-$1.7K	–	753
2022 Q4	$1.7K	Buy	+14,134	New	+$2.04K	﹤0.01%	541

Other funds holding HGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.7B AUM 31.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

StoneX Group's HGEN Position: Q1 2023 in Review

StoneX Group sold out of HUMANIGEN, INC. (HGEN) in Q1 2023, closing a stake of 14,134 shares — an estimated $1.7K sold.

StoneX Group first reported a position in HGEN in Q4 2022 and held it in 1 quarter. The position peaked at $1.7K in Q4 2022. 42 funds tracked by Wall St. Rank hold HGEN as of Q1 2023.

StoneX Group reported no remaining HUMANIGEN, INC. position as of Q1 2023 after selling out during the quarter.
StoneX Group sold 14,134 HUMANIGEN, INC. shares in Q1 2023, an estimated $1.7K.
StoneX Group first reported a position in HUMANIGEN, INC. in Q4 2022 and held it in 1 quarter.
StoneX Group's HUMANIGEN, INC. position peaked at $1.7K in Q4 2022.
42 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q1 2023.

Based on StoneX Group's 13F filing for Q1 2023, filed 11 May 2023.